The effect of short-and long-term feeding with L-carnitine, L-acetyl carnitine and L-propionyl carnitine on the production of eicosanoids from in vitro stimulated carrageenan-induced rat peritoneal macrophages was investigated. Both young (4 weeks) and old (18 months) rats were used. A lower number of cells was isolated from the peritonea of treated than control young rats after 4 d feeding, but after 60 d no differences were observed. A similar reduction in cell number was found when old animals were given L-acetyl carnitine or L-propionyl carnitine (acutely) or L-acetyl carnitine or L-carnitine (chronically). Plasma carnitine levels were higher in young rats given carnitine both chronically and acutely. Carnitine derivatives were without effect. In contrast, levels of total carnitine in the plasma of old rats given L-carnitine and Lacetyl carnitine for 4 d and 60 d were higher than in controls. There was no correlation between total plasma carnitine level and effects on prostaglandin, thromboxane and leukotriene B4 (LTBJ production. In young rats the most important changes were observed in relation to the production of prostacych (PGI3, measured as 6 keto-prostaglandin Flm. Prostacyclin production was higher in the groups given carnitine or its derivatives. The net result of the changes in PGI, was that the 6 keto-prostaglandin F,,:thromboxane B, and the 6 keto-prostaglandin F,,:LTB, ratios tended to be higher in cells from young animals following short-term feeding with ~carnitine. When young rats were given carnitine compounds for 60 d PGI, production was lower in cells from L-acetyl carnitine-and L-propionyl carnitine-fed animals. The net result of the changes in PGI, was that the 6 ketoprostaglandin F,,:thromboxane B, and the 6 keto-prostaglandin F,,:LTB, ratios were lower in cells from animals fed with carnitine compounds. In old rats the PGI, production was lower after short-term feeding with carnitine compounds and was higher after long-term feeding. LTB, production was lower after L-carnitine and L-acetyl carnitine treatment for 4 d and also lower after 60 d treatment with L-acetyl carnitine. The net results of the changes in PCL, were that the 6 keto-prostaglandin F,,:tbromboxane B, and the 6 keto-prostaglandin F,,:LTB4 ratios were lower after short-term feeding of all three compounds and higher after the long-term treatment with bacetyl carnitine and L-propionyl carnitine in old rats. By long-term treatment with low-dose aspirin of patients with heart failure and claudication, the 6 keto-prostaglandin F,,:thromboxane B, ratio is positively increased, which is a beneficial cardioprotective effect. The mechanism of action of carnitine in heart failure and claudication could also be achieved by an increase of this ratio. Our results suggest that elderly patients could be treated chronically by carnitine to obtain this beneficial effect. ~Carnitine : Peritoneal macrophages : Eicosanoids Before long-chain fatty acids are oxidized in mitochondria they are activated by acyl coenzyme A (acyl CoA) synthetase (EC 6.2.1.3) and carried across the mitochondria1 * Present address:
inner membrane by L-carnitine (P-hydroxy-(7-N-trimethy1amino)-butyrate). Carnitine deficiency, defined as a decrease in intracellular carnitine, leads to the accumulation of acyl CoA esters within the cell and an inhibition of acyl transport through the mitochondria1 inner membrane. Inhibition of the mitochondrial Boxidation results in fatty acid infiltration and, eventually, heart or liver failure (Barth et al. 1983; Scholte et al. 1989 Scholte et al. , 1990 Wanner et al. 1989) . Carnitine deficiency can be due to a genetic deficiency, or may occur as a side-effect of dialysis treatment. For example, serum carnitine and leucine levels were significantly decreased in patients on continuous ambulatory peritoneal dialysis (CAPD) for more than 4 months. This observation suggests that malabsorption plays a role in the reduction of serum carnitine levels in patients receiving CAPD (Murakami et al. 1990 ). The clinical conditions of infants and children with a variety of diagnoses associated with low circulating carnitine concentrations improved after carnitine supplementation, and carnitine has been reported to have several beneficial effects on ischaemic heart diseases and arrhythmias in man, where it augments the ischaemic heart tolerance to stress (Schinetti & Mmzini, 1986) .
Carnitine administration may also have beneficial effects in patients with disorders of NH, metabolism (Ohtsuka & Griffith, 1991 ; Rebouche, 1992) . Interestingly, adults suffering from chronic diseases associated with ageing, such as heart disease or cardiomyopathy due to carnitine loss, are improved by treatment with L-carnitine, L-acetyl carnitine or L-propionyl carnitine (Winter et al. 1987; Scholte et al. 1989 Scholte et al. , 1990 Wanner et al. 1989; Rebouche, 1992) .
Besides its stimulation of fatty acid oxidation, L-carnitine has also been shown to enhance the formation of arachidonic acid from linoleic acid by isolated hepatocytes. It was suggested that this was due to the removal of the inhibitory effect of long-chain acyl CoA on acetyl CoA carboxylase (EC 6.4.1 .2), a regulating enzyme in fatty acid synthesis, by long-chain acyl carnitine (McGarry et al. 1975; Christophersen & Norseth, 1981; Rebouche, 1986; Stryer, 1988; Conte et al. 1992) . This increased arachidonic acid synthesis could be important, as eicosanoids, metabolites of arachidonic acid, are important local modulators of inflammation. For example, the cyclooxygenase product prostaglandin E, (PGE,) is recognized as an important inhibitor of both cell migration and mediator formation, whereas leukotriene B, (LTB,), a lipoxygenase (EC 1.13.11.12) product, is a potent chemotactic agent which promotes the formation of mediators at inflammatory sites (Lehmann et al. 1988; Renz et al. 1988; Schepers et al. 1988; Yamaoka er al. 1988 ). Furthermore, the ratio between the vasoconstrictive prostanoid thromboxane A, (TxA,), synthesized by platelets, and the vasodilative prostacyclin (prostaglandin I, ; PGI,), synthesized by endothelial cells, is of importance in controlling platelet aggregation and adherence to blood vessels (Campbell, 1990) . CoA also plays a role in the formation and breakdown of products from both the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism (Conte et al. 1992) . Recently the oxidation of PGE, in rat liver peroxisomes and mitochondria was shown to require the activation to PGE, CoA by microsomal PGE, CoA synthetase (Schepers et al. 1988 ). Furthermore, LTB, is degraded through w-and b-oxidation in neutrophils and liver cells. The formation of LTB, CoA esters which occurs in rat-liver microsomes may be essential for LTB, ,&oxidation (Yamaoka et al. 1988) . While LTB, is a potent chemotactic agent and promotes the formation of mediators at inflammatory sites, its degradation products are less potent than the parent compound. Hence the formation of LTB, CoA esters and their subsequent poxidation might be of importance in limiting LTB, activity at the sites of inflammation. Thus, carnitine could stimulate both the synthesis and breakdown of eicosanoids by the same mechanism, i.e. reducing the concentration of long-chain acyl CoA within the cell.
Recently we showed that feeding young rats (3-4 months) with L-carnitine or various derivatives resulted in a preferential higher production of PGI, by peritoneal macrophages (Elliott et al. 1990 ). Our results could provide the basis for a possible explanation for the beneficial effects of carnitine and its derivatives in cardiovascular diseases. Such investigations into the mechanisms of L-carnitine and its derivatives may lead to the identification of new roles for these compounds.
In the present study we extended our investigations by examining the effect of L-carnitine, L-acetyl carnitine (formed during P-oxidation of even-chain fatty acids) and L-propionyl carnitine (formed during &oxidation of uneven-chain fatty acids) on eicosanoid production by carrageenan-induced peritoneal cells of young and old rats after 4 or 60 d exposure. Earlier results obtained using young rats given carnitine compounds for 4 d are shown for ease of comparison (Elliott et al. 1990) .
MATERIALS A N D METHODS

Materials
L-Carnitine, L-acetyl carnitine, and L-propionyl carnitine were gifts from Sigma-Tau Pharmaceutical Co. (Rome, Italy). Carrageenan was purchased from Marine Colloids Inc (Springfield, NJ, USA). Lymphoprep was from Nyegaard Diagnostica (Oslo, Norway) and Dulbecco's modified Eagle's medium was obtained from Life Technologies (Breda, The Netherlands). A23 187 was from Sigma (Axel, The Netherlands). 'H-labelled eicosanoids were from Amersham ('s-Hertogenbosch, The Netherlands) and antibodies from Advanced Magnetics Inc. (Cambridge, MA, USA). Other chemicals were purchased from Merck (Amsterdam, The Netherlands) and Sigma.
Animals
Male Wistar rats were used in all experiments. The animals were housed in groups of three in polyethylene cages with food and water ad lib. Artificial light was supplied in a 12 h light-dark cycle.
Treatment
Two series of experiments were carried out.
Short-term treatment. Young rats ( 3 4 months, nine rats per group) and old rats (16-18 months, five rats per group) were given by intubation on days 1 4 , 300 mg L-carnitine or carnitine equivalents (L-acetyl carnitine and L-propionyl carnitine)/kg dissolved in 1 ml distilled water. Control animals were given distilled water. All animals were injected intraperitoneally with 2 ml of a carrageenan solution (1 mg/ml) on day 1 (Elliott et al. 1990 ).
Long-term treatment. Young rats (3-4 months, nine rats per group) and old rats (16-18 months, five rats per group) were given in their drinking water on days 1-60, 50mg Lcarnitine or carnitine equivalents (L-acetyl carnitine and L-propionyl carnitine)/kg. Control animals were given water. All animals were injected intraperitoneally with 2ml of a carrageenan solution (1 mg/ml) on day 56 (4 d before the end of the experiment).
Isolation and incubation of peritoneal cells
On day 4 or 60, 1 h after the last administration of L-carnitine or its derivatives, cells were isolated from pooled Gey's balanced-salt solution washes of the peritonea of the rats by density-gradient centrifugation over Lymphoprep and suspended in Dulbecco's modified Eagle's medium (2 x loe nucleated cells/ml). The harvested peritoneal cell population consisted of > 85 % macrophages and > 10 % polymorphonuclear leucocytes. A 1 ml portion of cell suspension was incubated at 37" for either 2 h without ionophore (basal production) or 30 min with lo-' ~-A 2 3 187 (ionophore-stimulated production). The cell suspensions were then centrifuged and the supernatant fractions analysed for production of LTB,, PGE,, TxB,, and 6 keto-prostaglandin F,, (6 keto-PGF,J by radioimmunoassays (Zijlstra & Vincent, 1984; Elliott et al. 1990 ). The net eicosanoid production was calculated by subtraction of the basal production from the ionophore-stimulated production. Blood samples were taken for measurement of total plasma carnitine levels (Pande & Caramancion, 1981; Rossle et al. 1985) .
Statistical evaluation
In the experiments the values are given as means and standard deviations for either nine or five rats per group. Statistical significance was calculated using the Student's t test.
RESULTS
Results obtained using young rats fed with carnitine compounds for 4 d have been previously published (Elliott et al. 1990 ) and are given here solely for the purposes of comparison.
Cell number
Young rafs, short-term. All three compounds significantly reduced the number of nucleated cells isolated from peritonea 4 d after an intraperitoneal injection of carrageenan.
Young rats, long-term. No differences were found between the groups with respect to the number of nucleated peritoneal cells isolated after 60 d.
Old rats, short-term. L-Acetyl carnitine and L-propionyl carnitine significantly reduced the number of nucleated cells isolated from the peritonea after 4 d treatment.
Old rats, long-term. L-Carnitine and L-acetyl carnitine significantly reduced the number of nucleated cells isolated from the peritonea 60 d after treatment (Table 1) .
Plasma levels of carnitine
Of the three compounds used, only in the L-carnitine group was the total L-carnitine concentration in plasma higher in all experiments in comparison with the controls (Table 2 ). In the L-acetyl carnitine group the total L-carnitine concentration in the plasma of old rats (chronic and acute) was higher than in controls.
Table 2. Efect of shortand long-term feeding of L-carnitine or its congeners on the plasma levels (umolll) of carnitine in young and old rats?
(Values are means and standard deviations for nine (young) and five (old) rats) 
Production of eicosanoids from carrageenan-induced peritoneal cells Young rats.
In the short-term experiments the production of 6 keto-PGF,, and TxB, tended to increase with L-acetyl carnitine and L-propionyl carnitine (Fig. 1) . Production of 6 keto-PGF,, was significantly higher and that of TxB, tended to be higher after feeding with L-carnitine. LTB, production was significantly higher in all three treatment groups (Table 3) . However, no effects on PGE, formation were detected. The 6 keto-PGF,,:TxB, Table 3 
. Eflect of short-and long-term feeding of L-carnitine or its congeners on the net production of leukotriene B, (ng/2 x lo6 macrophages) from peritoneal cells in young and old rats?
(Values are means and standard deviations for nine (young) t For details of procedures, see pp. 787-788. and the 6 keto-PGF,,: LTB, ratios, calculated from the net values, tended to be higher with L-carnitine treatment (Tables 4 and 5) . This was due to the fact that the stimulation of 6 keto-PGF,, production was greater than that of the other eicosanoids measured (Elliott et al. 1990 ).
In the long-term experiments the 6 keto-PGF,, production was significantly lower in the L-acetyl carnitine and L-propionyl carnitine groups, while it was not in the L-carnitine group. No changes in PGE, production were detected (Fig. 1) . LTB, production was significantly lower after feeding L-propionyl carnitine (Table 3 ). This resulted in significantly lower 6 keto-PGF,,: TxB, and 6 keto-PGF,,: LTB, ratios after treatment with L-acetyl carnitine and L-propionyl carnitine, but a significantly higher 6 keto-PGF,, : TxB, ratio in the L-carnitine group compared with controls (Tables 4 and 5) .
Old rats. In the short-term experiments the production of 6 keto-PGF,, was significantly lower in all carnitine groups and the TxB, production was significantly lower in the L-propionyl carnitine group. No changes in PGE, production were detected (Fig. 1) . LTB, production was significantly lower after L-carnitine and L-acetyl carnitine treatments. The 6 keto-PGF,,: TxB, and 6 keto-PGF,, : LTB, ratios were significantly lower in all three treatment groups than in the control group. EfSect of short-and long-term feeding of L-carnitine or its congeners on the 6  keto-prostaglandin F,, : leukotriene B, ratio of peritoneal cells from young and old In the long-term experiments no significant effects on PGE, and TxB, production were detected. Only in the L-acetyl carnitine and the L-propionyl carnitine groups was a significantly lower production of 6 keto-PGF,, found ( Fig. 1) . LTB, production was significantly lower in the L-acetyl carnitine group after chronic exposure (Table 3 ). The 6 keto-PGF,,:TxB, ratio was significantly higher in all three treatment groups and the 6 keto-PGF,,: LTB, ratio was significantly higher in the chronic experiments after treatment with L-acetyl carnitine and L-propionyl carnitine (Tables 4 and 5) . DISCUSSION Only exposure to L-carnitine resulted in an elevation of total plasma L-carnitine in young rats (acute and chronic exposure). Both L-carnitine and acetyl carnitine treatment elevated total plasma L-carnitine in old rats. However, in view of the lack of a correlation between plasma Lcarnitine and other variables measured, the significance of these increases is not clear. One effect of feeding L-carnitine or its congeners to young rats for 4 d was the much lower number of carrageenan-elicited macrophages isolated from the peritonea of the treated animals. In contrast there was no effect when young rats were treated chronically. The effect of carnitine compounds on the number of elicited macrophages isolated from old rats was variable. Only in the L-acetyl carnitine group was a lower number of elicited macrophages found after both chronic and acute exposure. These results indicate that some L-carnitine compounds can modify the macrophage response to chemotactic signals generated when carrageenan is injected intraperitoneally. The exact effect depends on the age of the animal and time of exposure. A reduction of 50 YO in the number of macrophages at an inflammatory site could well be beneficial, for example in chronic immunoinflammatory diseases.
We previously demonstrated that PGI, production by rat and rabbit aortas increased with age (Adolfs & Elliott, 1982; Elliott & Adolfs, 1984; Vincent & Zijlstra, 1986 ). In the present study we also show that eicosanoid production by macrophages is increased with age. It now appears that an increase in the turnover of arachidonic acid could be a characteristic of ageing. From the short-term feeding experiments with older rats we conclude, in general, that L-carnitine and its derivatives inhibited PGI, production. In contrast, the production of PGI, after long-term feeding was stimulated. The net results of the changes in PGI, were that the 6 keto-prostaglandin F,,:thromboxane B, and the 6 keto-prostaglandin Fla: LTB, ratios were lower after short-term feeding of all three 1. M. G A R R E L D S A N D OTHERS compounds and higher in the long-term treatment with L-acetyl carnitine and L-propionyl carnitine in comparison with controls. The production of PGI, and TxB, from macrophages isolated from young test animals was higher than that from control rats after short-term feeding with L-carnitine and its derivatives. The results of these changes were that the 6 keto-PGF,,: TxB, ratio and 6 keto-PGF,,:TxB, ratio were higher after short-term Lcarnitine treatment. After long-term treatment with L-acetyl carnitine and L-propionyl carnitine a lower production of PGI, was observed. The net results were that the 6 ketoprostaglandin F,,: thromboxane B, and 6 keto-prostaglandin F1,: LTB, ratios were lower after feeding with L-acetyl carnitine and L-propionyl carnitine.
In man the 6 keto-PGF,,:TxB, ratio is positively increased by long-term low-dose aspirin treatment, despite the fact that aspirin inhibits prostaglandin formation. This is because although aspirin inhibits the synthesis of platelet thromboxane A,, a vasoconstrictor and platelet activator, and of vascular endothelium prostacyclin synthesis, a vasodilator and platelet inhibitor (Haslam & McClenaghan, 1981; Weksler et al. 1983; Kallmann et al. 1987) , the effect of aspirin on endothelium cyclooxygenase is much less than the effect on the platelets. The mechanism of action of carnitine in heart failure and claudication could be achieved by an increase in the 6 keto-PGF,,:TxB, ratio. Our results suggest that elderly patients could be treated chronically with carnitine to obtain this beneficial effect. Further clinical trials, in which both plasma eicosanoid levels and prostacyclin production are monitored, should be performed to test this hypothesis.
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